Joel Baglole

Joel Baglole

InvestorPlace Contributor

Joel Baglole has been a financial reporter for more than 20 years. For five years, Mr. Baglole was a staff reporter at The Wall Street Journal, where he wrote articles from Iceland to Indonesia and covered topics ranging from the automotive and airline industries to investment banks and global stock markets.

Mr. Baglole has also worked for The Washington Post and Toronto Star newspapers, and has contributed to business focused websites such as The Motley Fool and Investopedia. At InvestorPlace, he covers a wide range of large and small cap stocks, as well as political and economic issues that impact financial markets.

Check out Joel’s TipRanks profile.

Recent Articles

Don’t Give Up on Roku Stock Just Yet

By Joel Baglole, InvestorPlace Contributor

Despite its punishing decline over the past month, there is still hope for video streaming company Roku's stock. The San Jose, California-based company that develops television sets and other devices that connect directly to the Internet and also runs an advertising business has been in the penalty box since its last quarterly earnings report.

Buy And Hold Alibaba Stock for the Long-Term

By Joel Baglole, InvestorPlace Contributor

After a difficult year, hope is starting to emerge that better days are ahead of Chinese e-commerce giant Alibaba. Investors should be prepared to ride out periods of heightened uncertainty and volatility with BABA stock. Those concerns aside, it is a long-term buy.

FUTU Stock: What Is Going on With Futu Holdings Today?

By Joel Baglole, InvestorPlace Contributor

Chinese online brokerage Futu Holdings' stock is getting hit today on lingering concerns that regulators are going to crack down.

CERN Stock Alert: Cerner Pops 15% on Acquisition Speculation

By Joel Baglole, InvestorPlace Contributor

CERN stock is popping on rumors that the company could be acquired by Oracle for $30 billion in a blockbuster deal.

Teladoc Health’s Stock Is Likely To Be Revived

By Joel Baglole, InvestorPlace Contributor

Can shares of Teladoc Health be resuscitated? The Purchase, Harrison, New York-based company that facilitates telemedicine (virtual visits between doctors and patients) has seen its share price fall 55% this year to $88.81 as enthusiasm for healthcare services delivered online fizzles.

Load More